Puramed Bioscience Inc. Debt Instrument, Convertible, Beneficial Conversion Feature
Puramed Bioscience Inc. reported Debt Instrument, Convertible, Beneficial Conversion Feature of $121.19 thousand for the 6-month period ending 2011-12-31, per its 10-Q filed 2012-02-14.
Discontinued › Notes › Debt › Debt Instruments
us-gaap:DebtInstrumentConvertibleBeneficialConversionFeature · last filed 2012-02-14
| Period end | Debt Instrument, Convertible, Beneficial Conversion Feature 6 month | Debt Instrument, Convertible, Beneficial Conversion Feature 12 month |
|---|---|---|
| 2011-12-31 | $121.19K 10-Q · filed 2012-02-14 | |
| 2011-06-30 | $245.00K 10-Q · filed 2012-02-14 |